Chemical Profiling and Anticancer Potential of Apium graveolens Seed Essential Oil: In Vitro Assessment in Melanoma and Pancreatic Cancer and In Silico Analysis in Melanoma
Year: 2026
Type: article
Abstract: Although the essential oil (EO) extracted from the seeds of A. graveolens (APM EO) has garnered considerable interest in recent years due to its wide range of biological activities, its cytotoxic effects against melanoma and pancreatic cancer, as well as the molecular targets potentially involved in these effects, remain insufficiently explored. The current study, designed to address this knowledge gap, combines chemical characterization with in vitro and in silico evaluations through network pharmacology and molecular docking of APM EO activity and potential molecular targets. GC-MS revealed the presence of D-limonene as a major component (83.33%) accompanied by β-selinene (4.78%) in a smaller proportion. Cell viability was assessed in A375 melanoma, PANC-1 pancreatic adenocarcinoma and immortalized keratinocyte HaCaT cells following 24 h exposure to 10–250 µg/mL APM EO. Treatment reduced cancer cell viability in a concentration-dependent manner, with IC50 values of 113.02 μg/mL in A375 and 151.9 μg/mL in PANC-1 cells, while HaCaT cells exhibited lower sensitivity (IC50 > 250 μg/mL). Immunofluorescence revealed the occurrence of nuclear condensation and altered β-actin distribution in treated cells, revealing morphological changes suggestive of apoptosis. Network pharmacology identified STAT3 and PTGS2 (COX-2) as potential melanoma-associated targets. Molecular docking revealed favorable predicted binding affinities for β-selinene and α-selinene toward PTGS2 (−8.2 and −8.3 kcal/mol, respectively), caryophyllene oxide yielded a docking score of −5.3 kcal/mol toward STAT3. Overall, the findings provide initial experimental evidence of APM EO activity against melanoma and pancreatic adenocarcinoma cells, together with computational prediction of potential molecular targets in melanoma, and justify the need for future preclinical investigations of APM EO in terms of the experimental validation of its cell death mechanisms, target engagement and selectivity.
Source: Applied Sciences
DOI: 10.3390/app162211439
Authors: Iasmina-Denisa Boantă(Data curation, Formal analysis, Investigation, Methodology, Writing – original draft), Roxana Racoviceanu(Conceptualization, Methodology, Resources, Supervision, Writing – original draft), Alexandra Prodea(Formal analysis, Methodology, Writing – original draft), Ioana Zinuca Magyari-Pavel(Resources, Validation, Writing – review & editing), Gabriela Antal(Data curation, Investigation), Elisabeta Atyim(Formal analysis, Software, Writing – original draft), Alexandra Mioc(Formal analysis, Methodology, Software, Writing – original draft), Alexandra Teodora Lukinich-Gruia(Formal analysis, Software, Visualization), Maria-Alexandra Pricop(Data curation, Investigation, Visualization), Andreea-Maria Munteanu(Investigation, Visualization), Andreea Munteanu(Investigation, Visualization), Codruța Șoica(Conceptualization, Supervision, Validation, Writing – review & editing), Christian Banciu(Resources, Validation, Writing – review & editing)
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,896
OpenAlex ID: W7236404357
